First‐in‐human development of a pharmacodynamic biomarker for PAC1 receptor antagonists using intradermal injections of maxadilan

Abstract Maxadilan, a potent vasodilator peptide, selectively activates the PAC1 receptor, a promising target for migraine therapy. Therefore, maxadilan has been suggested as a tool to study the pharmacodynamics (PDs) of PAC1 receptor antagonists. The objectives of this first‐in‐human study were to:...

Full description

Saved in:
Bibliographic Details
Main Authors: Heleen Marynissen (Author), Linde Buntinx (Author), Dorien Bamps (Author), Marleen Depre (Author), Els Ampe (Author), Anne Van Hecken (Author), Kristin Gabriel (Author), Steve Sands (Author), Gabriel Vargas (Author), Jan de Hoon (Author)
Format: Book
Published: Wiley, 2022-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available